Evidence map›Paper›PMID 37190113›Full record

ReviewCells2023

The Multifaceted Role of WNT Signaling in Alzheimer's Disease Onset and Age-Related Progression.

William W Kostes, David A Brafman

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Restoration of sFRP3 Preserves the Neural Stem Cell Pool and Spatial Discrimination Ability in a Mouse Model of Alzheimer's Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  8. Article
  9. Exploring the Impact of 3-Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Contextualizing molecular and structural aging across human organs.medRxiv : the preprint server for health sciences · 2025
    Article
  14. Excess Wnt in neurological disease.The Biochemical journal · 2025
    Review
  15. Review
  16. Targeting Ferroptosis/Nrf2 Pathway Ameliorates AlClInternational journal of molecular sciences · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

William W KostesSchool of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ 85287, USA.
David A BrafmanSchool of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ 85287, USA.
Arizona State University · US

Funding

Investigating the mechanisms of a multi-state model of Wnt signalingR01GM121698 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI BRAFMAN, DAVID A · 2017 to 2021
$1.7M
Generation and characterization of isogenic hiPSC lines with various APOE genotypesR21AG056706 · NIA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI BRAFMAN, DAVID A · 2017 to 2018
$409k
NIA NIH HHS R21 AG056706NIA NIH HHS R21AG056706NIGMS NIH HHS R01 GM121698
6 · The paper itself

Abstract

The evolutionary conserved WNT signaling pathway orchestrates numerous complex biological processes during development and is critical to the maintenance of tissue integrity and homeostasis in the adult. As it relates to the central nervous system, WNT signaling plays several roles as it relates to neurogenesis, synaptic formation, memory, and learning. Thus, dysfunction of this pathway is associated with multiple diseases and disorders, including several neurodegenerative disorders. Alzheimer's disease (AD) is characterized by several pathologies, synaptic dysfunction, and cognitive decline. In this review, we will discuss the various epidemiological, clinical, and animal studies that demonstrate a precise link between aberrant WNT signaling and AD-associated pathologies. In turn, we will discuss the manner in which WNT signaling influences multiple molecular, biochemical, and cellular pathways upstream of these end-point pathologies. Finally, we will discuss how merging tools and technologies can be used to generate next generation cellular models to dissect the relationship between WNT signaling and AD.

Indexed as

Alzheimer DiseaseCognitive DysfunctionAnimalsCentral Nervous SystemNeurogenesisWnt Signaling PathwayAlzheimer’s diseaseamyloidcentral nervous systeminflammationsynaptic functiontauWNT

Identifiers

PMID37190113
PMCPMC10136584
OpenAlexW4366690730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.